Tag: quality metrics

Linking Metrics and KPIs to Vendor and Site Performance Reviews In the landscape of oncology clinical research, ensuring effective vendor and site performance is crucial. This guide serves as a comprehensive tutorial for clinical operations, regulatory affairs, and medical affairs professionals to navigate the intricate relationship between metrics, KPIs, and performance reviews. The objective is…

Read More “Linking Metrics and KPIs to Vendor and Site Performance Reviews” »

Inspection Case Studies Highlighting the Power of Good Quality Metrics Inspection Case Studies Highlighting the Power of Good Quality Metrics In the dynamic field of clinical research and trials, ensuring high-quality data management and robust enrollment strategies is critical to success. Particularly, central labs for clinical trials play a pivotal role in managing these data…

Read More “Inspection Case Studies Highlighting the Power of Good Quality Metrics” »

Avoiding Metric Overload: Focusing on a Critical Few Indicators Avoiding Metric Overload: Focusing on a Critical Few Indicators Introduction to Key Performance Indicators in Clinical Trials In the realm of clinical trial management, particularly in oncology clinical research, the primary objective often revolves around patient safety and data integrity. As trials become more complex, numerous…

Read More “Avoiding Metric Overload: Focusing on a Critical Few Indicators” »

Back-Testing KRIs and QTLs Against Historical Trial Performance Back-Testing KRIs and QTLs Against Historical Trial Performance In today’s evolving landscape of clinical trials, ensuring quality and metrics that drive informed decision-making is more critical than ever. Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs) play essential roles in monitoring and improving clinical trial performance,…

Read More “Back-Testing KRIs and QTLs Against Historical Trial Performance” »

Metric Governance: Thresholds, Ownership and Review Cadence Metric Governance: Thresholds, Ownership and Review Cadence In the ever-evolving landscape of clinical research, the governance of metrics used to assess and ensure the quality of trials is paramount. Clinical trials must adhere to stringent regulatory frameworks imposed by bodies such as the FDA, EMA, and MHRA. This…

Read More “Metric Governance: Thresholds, Ownership and Review Cadence” »

Visualizing Quality Metrics for Senior Leadership and Study Teams Visualizing Quality Metrics for Senior Leadership and Study Teams Clinical trials are fundamental to the advancement of medical research and patient care. The ability to visualize quality metrics in a way that is understandable to senior leadership and study teams is critical for effective clinical trial…

Read More “Visualizing Quality Metrics for Senior Leadership and Study Teams” »

Regulatory Guidance and Expectations for QTLs in Pivotal Trials Regulatory Guidance and Expectations for QTLs in Pivotal Trials In the evolving landscape of precision medicine clinical trials, the necessity for stringent quality control and the implementation of Quality Tolerance Limits (QTLs) become paramount. This article serves as a comprehensive guide for clinical operations, regulatory affairs,…

Read More “Regulatory Guidance and Expectations for QTLs in Pivotal Trials” »

Data Sources and Integration Challenges for Clinical Quality KPIs Data Sources and Integration Challenges for Clinical Quality KPIs In the fast-evolving landscape of clinical trials, the drive for efficiency and data quality is paramount. Understanding the challenges associated with data sources and the integration of clinical quality Key Performance Indicators (KPIs) is crucial for clinical…

Read More “Data Sources and Integration Challenges for Clinical Quality KPIs” »

Using KRIs and QTLs to Trigger Risk Reviews and CAPA Actions Using KRIs and QTLs to Trigger Risk Reviews and CAPA Actions Introduction to Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs) In the realm of clinical trials, ensuring adherence to good clinical practice (GCP) is paramount for maintaining the integrity of study data…

Read More “Using KRIs and QTLs to Trigger Risk Reviews and CAPA Actions” »

Site-Level vs Study-Level Metrics: Granularity That Drives Action In the domain of clinical trials, monitoring and managing performance using metrics is essential for achieving regulatory compliance and ensuring the success of investigational products. This article delineates the critical distinctions between site-level and study-level metrics, highlighting the importance of granularity in driving actionable insights and promoting…

Read More “Site-Level vs Study-Level Metrics: Granularity That Drives Action” »